London hospital barred Letby trial expert from treating patients in 2023


University College London Hospitals acted over patient-safety concerns during Lucy Letby’s trial. It notified the medical regulator less than three weeks after Prof Peter Hindmarsh’s final testimony.
University College London Hospitals barred prosecution expert Prof Peter Hindmarsh from treating patients during Lucy Letby’s trial in March 2023 over concerns about patient safety, The Guardian said. The hospital trust told the doctors’ regulator of the bar on 15 March 2023, less than three weeks after his final day of testimony. The jury was not told about it.
Hindmarsh, a specialist in children’s hormones, testified at Manchester Crown Court that tests and medical records showed two babies had been poisoned with insulin, most likely put into intravenous fluid bags. Prosecutors alleged Letby injected the insulin, although there was no direct or forensic evidence that she or anyone else had done so.
Letby, a neonatal nurse at the Countess of Chester Hospital, was convicted of murdering 7 babies and attempting to murder 7 others and received 15 whole-life prison terms. She maintains her innocence, and the Court of Appeal refused her applications to appeal.
Hospital medical director Dr Tim Hodgson told the General Medical Council that Hindmarsh had breached a supervision order by giving independent advice about 3 children. In 2 cases, Hodgson said, Hindmarsh advised families to stop giving insulin at home. Hodgson said the trust could not accept the apparent risk to children even with close supervision.
The restrictions followed concerns reported to the regulator by Great Ormond Street Hospital about Hindmarsh’s diagnosis and treatment of patients, including cases of alleged harm. The hospital ended his contract in July 2022. The regulator opened an investigation on 25 November 2022, and a tribunal restricted him to working at University College London Hospitals with supervised clinical work in January 2023 while the investigation continued, saying he might otherwise pose a real risk to the public.
After the hospital barred him from treating patients, the regulator sought to suspend his registration. In April 2023, a tribunal instead ordered direct supervision for clinical work and allowed him to continue non-clinical work, including as an expert witness; it considered suspension disproportionate. Hindmarsh applied to leave the medical register in November 2024. The regulator allowed his removal, ending the investigation without a final finding.
Hindmarsh told Cheshire Constabulary about the regulator’s investigation in December 2022. The Crown Prosecution Service told Letby’s defense barrister, Ben Myers KC, in February 2023, but said it would oppose informing the jury because the investigation had not reached a final decision.
The defense was not told about the later clinical bar or tribunal ruling. The prosecution service said it had not been made aware of either; whether Hindmarsh told police about them remains unclear. The Guardian said the defense might otherwise have challenged his credibility and asked the judge to inform the jury or exclude his evidence.
Tim Green KC, a disclosure specialist, said an expert witness’s duty to disclose material that could undermine an opinion or credibility continues after testimony and through proceedings and appeals. In his view, further professional tribunal restrictions must also be disclosed.
The prosecution service said it met all its disclosure obligations and that the defense raised no objection to its expert evidence. A representative for Hindmarsh said he had no comment on the questions put to him.
Lead prosecutor Nick Johnson KC described Hindmarsh to jurors as the pre-eminent expert on insulin and presented the alleged insulin poisonings as incontrovertible. In his summing up, Judge James Goss told jurors that if they were sure babies were deliberately harmed, they could decide other babies were also harmed even if they were unsure of the precise cause.
Experts whose reports support Letby’s review application dispute Hindmarsh’s calculations and diagnoses and say the evidence does not support insulin being put into the fluid bags. They also say the blood tests used by the prosecution, known as immunoassays, can react to antibodies and produce falsely high insulin results.
The insulin allegations were not simply another part of the prosecution’s case; they were its cornerstone, presented as scientific proof that she had deliberately poisoned babies and was capable of murder.
McDonald said the insulin allegations also shaped the jury’s view of the other allegations. The Criminal Cases Review Commission, which examines possible miscarriages of justice, says its review of Letby’s convictions is underway. It received a preliminary application on 3 February 2025, followed by further submissions and expert reports through 21 January 2026.
The commission says it can refer a conviction back for appeal when new evidence or argument creates a real possibility that the appeal court will overturn it. If it refers Letby’s case, the court would decide whether her convictions stand.
UNICEF is expanding emergency aid in Yemen, where at least 64 children have been killed and 64 injured since fighting intensified on 3 September 2026. It warns that child casualties are likely to rise if fighting continues near populated areas.
3 min

The two governments want TikTok’s European business to move out of Chinese parent ByteDance’s control, but have not specified an ownership structure or legal route.
3 min

Georgia’s Prosecutor’s Office announced the verdict on 18 November 2026. The court found the former police officers guilty of exceeding their official authority with violence at a police station in Kobuleti.
2 min